- Home
- / Handa Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Handa Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
NT$66.9
2024-10-29
Market Capitalization
NT$9.2 B
2024-10-29
Revenue
NT$830.7 M
FY, 2024
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| TWD | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 93.7M | 84.1M | 28.9M | 29.2M | 197.7M | 1.1B | 830.7M |
| Cost of goods sold | 35.9M | 15.4M | 1.4M | 1.5M | 18.7M | 1.3M | 1.2M |
| Gross profit | 67.9M | 76.3M | 40.8M | 28.1M | 179.7M | 1.2B | 829.5M |
| Gross profit margin, % | 90.8% | 141.2% | 96.0% | 90.9% | 106.4% | 99.9% | |
| Operating expense total | 249.5M | 255.7M | 328.3M | 265.2M | 251.9M | 399.1M | 401.0M |
| Depreciation and amortization | 23.0M | 18.0M | 21.1M | 16.5M | 15.2M | 12.4M | 10.4M |
| EBITDA | (181.6M) | (179.4M) | (287.6M) | (237.1M) | (72.2M) | 785.3M | 426.7M |
| EBITDA margin, % | -213.3% | -996.4% | -811.0% | -36.5% | 71.0% | 51.4% | |
| EBIT | (204.8M) | (199.1M) | (308.7M) | (253.6M) | (87.4M) | 772.8M | 395.7M |
| EBIT margin, % | -236.9% | -1069.6% | -867.4% | -44.2% | 69.9% | 47.6% | |
| Interest income | 3.0M | 289.0K | 502.0K | 18.2M | 57.1M | ||
| Interest expense | 436.0K | 453.0K | 232.0K | 281.0K | 222.0K | 492.0K | |
| Pre tax profit | (191.8M) | (203.1M) | (320.4M) | (260.8M) | (43.1M) | 792.5M | 479.2M |
| Income tax expense | (25.3M) | (25.4M) | (38.3M) | (13.1M) | (3.1M) | 65.6M | 6.4M |
| Net Income | (166.5M) | (177.7M) | (282.1M) | (247.7M) | (40.0M) | 726.9M | 472.7M |